The original success of Viagra undeniably revolutionized the medication landscape, but investing in companies strongly reliant on unbranded versions presents a uncertain picture. While early returns were significant, the end of patents and the appearance of discounted alternatives have diminished sales. Consequently, a thorough analysis of present